부산대학교 도서관

The main purpose of investigational phase II clinical trials is to explore indications and effective doses. However, as yet, there is no clear rule and no related published literature about the precise suitable sample sizes to be used in phase II clinical trials. To explore this, we searched for clinical trials in the ClinicalTrials.gov registry using the keywords "dose-finding" or "dose-response" and "Phase II". The time span of the search was September 20, 1999, to December 31,2013. A total of 2103 clinical trials were finally included in our review. Regarding sample sizes, 1,156 clinical trials had 100 patient cases in a single group. Sample sizes used in parallel study designs tended to be larger than those of crossover designs (median sample size 151 and 37, respectively). In conclusion, in the earlier phases of drug research and development, there are a variety of designs for dosage investigational studies. The sample size of each trial should be comprehensively considered and selected according to the study design and purpose. Keywords: sample number, dose-finding, dose-response, systematic review
Introduction The stages of clinical trials for drugs in development can be divided into four phases. The main purpose of the first clinical stage, phase I, is to observe the [...]